Te Ahumairangi Investment Management Ltd Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Te Ahumairangi Investment Management Ltd reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,776 shares of the healthcare conglomerate's stock after selling 1,000 shares during the period. Te Ahumairangi Investment Management Ltd's holdings in UnitedHealth Group were worth $3,428,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $32,000. Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at $40,000. Finally, DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after acquiring an additional 62 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Up 0.1 %

Shares of NYSE UNH traded up $0.49 during mid-day trading on Wednesday, reaching $523.61. 2,368,702 shares of the company were exchanged, compared to its average volume of 4,235,187. The stock has a market cap of $478.95 billion, a price-to-earnings ratio of 33.78, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a 50-day moving average of $509.15 and a 200 day moving average of $542.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.83 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group's payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

Several research firms recently commented on UNH. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. KeyCorp restated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.